Equities

Encision Inc

ECIA:PKC

Encision Inc

Actions
  • Price (USD)0.42
  • Today's Change0.00 / 0.00%
  • Shares traded12.50k
  • 1 Year change+5.00%
  • Beta0.4715
Data delayed at least 15 minutes, as of Nov 08 2024 20:01 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Encision Inc. is a medical device company. It designs, develops, manufactures and markets patented surgical instruments that provide safety to patients undergoing minimally invasive surgery. Its segments include Product and Service. Product segment designs, develops, manufactures and markets patented surgical instruments. Service segment performs electrical engineering activities for external entities. Its Active Electrode Monitoring (AEM) technology provides surgeons with the desired tissue effects of cutting and coagulating tissue in laparoscopic procedures, while preventing stray electrosurgical energy that can cause complications and even death. It produces and markets a full line of AEM Instruments, which are shielded and monitored to prevent stray electrosurgical burns from insulation failure and capacitive coupling. Its product line includes a range of endo-mechanical instruments, such as scissors, graspers and dissectors, fixed-tip electrodes and suction-irrigation electrodes.

  • Revenue in USD (TTM)6.56m
  • Net income in USD-529.29k
  • Incorporated1991
  • Employees22.00
  • Location
    Encision Inc6797 Winchester CircleBOULDER 80301United StatesUSA
  • Phone+1 (303) 444-2600
  • Fax+1 (303) 444-2693
  • Websitehttps://www.encision.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Reflect Scientific Inc1.73m-53.09k4.07m7.00--2.0752.832.35-0.0006-0.00060.02030.0230.71970.846317.05247,638.60-2.2011.10-2.5913.2158.1962.48-3.0610.005.68--0.00---47.09-6.99-613.46------
AccuStem Sciences Inc0.00-1.65m4.14m3.00---------0.1454-0.14540.00-0.25420.00----0.00-551.46--------------------------45.26------
Dror Ortho-Design Inc0.00-5.63m4.31m4.00--2.60-----0.012-0.0120.000.00340.00-------577.48-140.50-1,394.24---------118,188.00----0.00-------1,896.02------
Kelyniam Global Inc517.70k-420.28k4.42m0.00--8.17--8.54-0.0253-0.02530.03120.01790.41357.044.38---33.57---41.79--18.86---81.18--1.26--0.6232---26.47---19.10------
Predictive Oncology Inc1.75m-14.04m4.93m34.00--1.03--2.82-3.36-3.360.41580.71710.11081.454.2851,425.29-88.98-91.80-121.17-126.2960.2364.64-802.93-1,419.991.37--0.0634--18.244.7545.67--5.44--
Encision Inc6.56m-529.29k4.99m22.00--2.68--0.7599-0.045-0.0450.5560.15661.702.107.59298,337.30-13.69-3.03-19.50-4.1349.0051.25-8.06-1.891.01-8.890.1761---10.38-5.64-113.55---9.54--
Sharps Technology Inc0.00-8.21m5.05m3.00--0.5059-----10.88-10.880.005.550.00-------75.56---100.97----------0.6446--0.00-------112.12------
ADM Tronics Unlimited Inc3.06m-472.80k5.07m7.00--4.97--1.66-0.007-0.0070.04530.01511.113.725.67---17.14-15.22-29.35-22.0942.8741.15-15.45-18.580.8954--0.3259---19.35-0.3572-810.74------
Orgenesis Inc662.00k-29.02m5.34m146.00------8.07-8.68-8.680.2005-3.300.027278.295.384,534.25-122.18---1,312.10---101.06---4,489.28--0.0741-5.85-----98.53-50.94-271.82---17.71--
Bionoid Pharma Inc0.001.35m5.40m13.000.0882--3.99--1.131.130.00-0.1744-----------506.64--------------327.24---------31.55--26.01--
Aethlon Medical, Inc.0.00-11.50m5.62m14.00--0.6447-----3.87-3.870.000.62510.00----0.00-84.49-76.25-98.84-85.78-------2,246.87----0.00---100.00---1.43------
Agape ATP Corp1.38m-2.45m5.73m21.00--1.78--4.16-0.6396-0.63960.35990.83660.44648.2536.6665,621.91-78.78---111.56--64.23---176.47--4.66--0.0225---22.92---24.61------
Caduceus Software Systems Corp0.00-117.60k5.78m0.00---------0.0004-0.00040.00-0.00040.00-------402.19-11,090.31---------------76.88---------20,519.89------
Optimus Healthcare Services Inc1.89m-7.16m5.94m12.00------3.15-0.1744-0.17440.0454-0.18891.26--3.67157,291.70-477.28------85.93---379.51-----5.42----22.88---3.51------
Bioelectronics Corp1.61m-289.82k6.18m9.00------3.84-0.00002-0.000020.00007-0.00066.329.2014.53---113.86-383.59----49.4351.48-18.01-143.480.0099-0.4909----94.01-5.0975.01------
Biomerica Inc5.51m-6.16m6.56m63.00--1.23--1.19-0.3663-0.36630.32740.31780.52232.633.6987,412.70-58.44-44.68-71.68-51.738.8114.11-111.89-63.822.09--0.00--1.420.810916.27---7.64--
Data as of Nov 08 2024. Currency figures normalised to Encision Inc's reporting currency: US Dollar USD

Institutional shareholders

8.12%Per cent of shares held by top holders
HolderShares% Held
DAFNA Capital Management LLCas of 31 Dec 2023964.66k8.12%
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.